Dianthus Therapeutics (DNTH) PT Raised to $130 at Clear Street
Tweet Send to a Friend
Clear Street analyst Bill Maughan raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $130.00 (from $100.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
